Cargando…

Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management

Diabetes, a metabolic disease characterized by high blood glucose and other complications, has undefined causes and multiple risk factors, including inappropriate diet, unhealthy lifestyles, and genetic predisposition. The two most distinguished types of diabetes are type 1 and type 2 diabetes, resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Tiange, Lin, Jiaran, Wang, Mina, Zhao, Yihan, Liao, Zehuan, Wei, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484715/ https://www.ncbi.nlm.nih.gov/pubmed/34603195 http://dx.doi.org/10.3389/fendo.2021.630032

Ejemplares similares

Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
por: Wang, Mina, et al.
Publicado: (2020)

Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer
por: Wang, Mina, et al.
Publicado: (2021)

Editorial: Non-coding RNA in diabetes and cardiovascular diseases
por: Macvanin, Mirjana T., et al.
Publicado: (2023)

PPAR-α Modulators as Current and Potential Cancer Treatments
por: Tan, Yan, et al.
Publicado: (2021)

Editorial: Role of long non-coding RNA and Circular RNA in bone metabolism and their role as circulating biomarkers for bone diseases
por: Faraldi, Martina, et al.
Publicado: (2023)

The Big Entity of New RNA World: Long Non-Coding RNAs in Microvascular Complications of Diabetes
por: Raut, Satish K., et al.
Publicado: (2018)

Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease
por: Li, Chengshun, et al.
Publicado: (2022)

PPAR-γ Modulators as Current and Potential Cancer Treatments
por: Chi, Tiange, et al.
Publicado: (2021)

Development and validation of a novel nomogram for prediction of ketosis-prone type 2 diabetes
por: Min, Rui, et al.
Publicado: (2023)

A long non-coding RNA that harbors a SNP associated with type 2 diabetes regulates the expression of TGM2 gene in pancreatic beta cells
por: González-Moro, Itziar, et al.
Publicado: (2023)

The More the Merrier—Complexity in Long Non-Coding RNA Loci
por: Ziegler, Christian, et al.
Publicado: (2017)

The Long Non-Coding BC200 Is a Novel Circulating Biomarker of Parathyroid Carcinoma
por: Morotti, Annamaria, et al.
Publicado: (2022)

Emerging Role of Long Non-Coding RNAs in Diabetic Vascular Complications
por: Tanwar, Vinay Singh, et al.
Publicado: (2021)

Roles of extracellular vesicles associated non-coding RNAs in Diabetes Mellitus
por: Gauthier, Benoit R., et al.
Publicado: (2022)

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs
por: Macvanin, Mirjana T., et al.
Publicado: (2023)

Editorial: Novel Biomarkers for Type 2 Diabetes
por: Ahluwalia, Tarunveer S., et al.
Publicado: (2019)

Long non-coding RNAs in bone metastasis: progresses and perspectives as potential diagnostic and prognostic biomarkers
por: Maroni, Paola, et al.
Publicado: (2023)

Non-Coding RNAs and Extracellular Vehicles: Their Role in the Pathogenesis of Gestational Diabetes Mellitus
por: Zhang, Tie-Ning, et al.
Publicado: (2021)

Serum miRNA Profile in Diabetic Patients With Ischemic Heart Disease as a Promising Non-Invasive Biomarker
por: Bielska, Agnieszka, et al.
Publicado: (2022)

Profile Screening of Differentially Expressed lncRNAs of Circulating Leukocytes in Type 2 Diabetes Patients and Differences From Type 1 Diabetes
por: Lv, Jianyi, et al.
Publicado: (2022)

Long Non-coding RNAs: A New Regulatory Code for Osteoporosis
por: Wu, Qian-Yuan, et al.
Publicado: (2018)

Emerging Classes of Small Non-Coding RNAs With Potential Implications in Diabetes and Associated Metabolic Disorders
por: Jacovetti, Cécile, et al.
Publicado: (2021)

Abnormal T-Cell Development in the Thymus of Non-obese Diabetic Mice: Possible Relationship With the Pathogenesis of Type 1 Autoimmune Diabetes
por: Mendes-da-Cruz, Daniella A., et al.
Publicado: (2018)

Incidence of Type 2 Diabetes in Kuwaiti Children and Adolescents: Results From the Childhood-Onset Diabetes Electronic Registry (CODeR)
por: Al-Kandari, Hessa, et al.
Publicado: (2019)

Development of predictive nomograms clinical use to quantify the risk of diabetic foot in patients with type 2 diabetes mellitus
por: Peng, Bocheng, et al.
Publicado: (2023)

Diabetes and cancer: Epidemiological and biological links
por: Wang, Mina, et al.
Publicado: (2020)

Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes
por: Wang, Zongyi, et al.
Publicado: (2022)

MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications
por: Vaishya, Suniti, et al.
Publicado: (2018)

MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy
por: Greco, Marta, et al.
Publicado: (2020)

Text mining-based identification of promising miRNA biomarkers for diabetes mellitus
por: Li, Xin, et al.
Publicado: (2023)

Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes
por: Yip, Linda, et al.
Publicado: (2020)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
por: Yang, Jiaying, et al.
Publicado: (2023)

Circulating biomarkers during progression to type 1 diabetes: A systematic review
por: Brenu, Ekua W., et al.
Publicado: (2023)

Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanism
por: Josefsen, Knud, et al.
Publicado: (2022)

A Qualitative Exploration of Self-Management Behaviors and Influencing Factors in Patients With Type 2 Diabetes
por: Peng, Xi, et al.
Publicado: (2022)

The gene regulatory role of non-coding RNAs in non-obstructive azoospermia
por: Zhou, Guanqing, et al.
Publicado: (2022)

Long non‐coding RNA screening and identification of potential biomarkers for type 2 diabetes
por: Ma, Qi, et al.
Publicado: (2022)

The Potential Use of DNA Methylation Biomarkers to Identify Risk and Progression of Type 2 Diabetes
por: Gillberg, Linn, et al.
Publicado: (2015)

Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
por: Willmer, Tarryn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_llstvo5m00f251dhol31mr966d